CellWell record HH-459475
Chronic inflammation is not associated with attenuated sodium-glucose co-transporter 2 inhibitor-induced hemoglobin increase in patients with diabetes
Miho Murashima; Kodai Suzuki; Takahisa Kasugai; Yuki Miyaguchi; Maki Hiratsuka; Tatsuya Tomonari; Minamo Ono; Masashi Mizuno; Tomohiro Tanaka; Takayuki Hamano
2026
In plain language
In patients with diabetes, starting SGLT2 inhibitors was associated with rising hemoglobin over six months, and this held whether chronic inflammation (CRP) was low or high.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-459475
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.